Denali Therapeutics Inc. Common Stock (DNLI) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for DNLI. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 14,026,413 | $361M | INCREASED |
| Baillie Gifford | 11,960,230 | $308M | DECREASED |
| State Street | 7,049,304 | $181M | INCREASED |
| Temasek Holdings (Private) | 7,012,974 | $180M | UNCHANGED |
| Pictet Asset Management Holding | 2,791,206 | $72M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP (Director) | AWARD | 19,226 | $378K | 2026-06-03 |
| BAKER BROS. ADVISORS LP (Director) | AWARD | 6,408 | 2026-06-03 | |
| Jennifer E. Cook (Director) | AWARD | 19,226 | $378K | 2026-06-03 |
| Jennifer E. Cook (Director) | AWARD | 6,408 | 2026-06-03 | |
| Timothy Van Hauwermeiren (Director) | AWARD | 19,226 | $378K | 2026-06-03 |
Full institutional holdings, insider history, and congressional trades for Denali Therapeutics Inc. Common Stock on SentiSense.